Skip to main content

Call for papers - Drug delivery systems

Guest Editor

Jayanta Kumar Patra, MSc, PhD, PDF, Dongguk University, Republic of Korea

Submission Status: Open   |   Submission Deadline: 15 August 2024

BMC Chemistry is calling for submissions to our Collection on Drug delivery systems, focusing on new research pushing the boundaries of drug delivery technology and paving the way for more effective and patient-centric therapeutic interventions.

Meet the Guest Editor

Back to top

Jayanta Kumar Patra, MSc, PhD, PDF, Dongguk University, Republic of Korea

Dr Jayanta Kumar Patra, MSc, PhD, PDF, is an Associate Professor at Dongguk University, Republic of Korea. He has around 14 years of research experience in the fields of pharmacology and nano-biotechnology. His current research focuses on nanoparticle synthesis by green technology methods and associated biomedical applications: green synthesis of silver, gold, iron, calcium, and phosphorous nanoparticles using food waste, agricultural waste, and plant materials and evaluation of their antibacterial, antioxidant, and cytotoxicity potential. Dr Patra has published >150 articles in various national and international peer-reviewed journals and around 35 book chapters. He is the editor of 20 books covering nanotechnology in pharmacology, biomedicine, and food sciences, including titles published with Apple Academic Press, CRC Press, Elsevier, and Springer. He is currently an editorial board member of >10 international journals, including Artificial Cells, Nanomedicine, Biotechnology, BMC Complementary and Alternative Medicine, Frontiers in Nanotechnology, and Frontiers in Sustainable Food Systems.

About the Collection

BMC Chemistry is calling for submissions on drug delivery systems. Drug delivery systems are pivotal in ensuring the precise and controlled release of therapeutic agents, which can significantly improve patient outcomes and treatment regimens. Innovations in this field have revolutionized our approaches to administering therapeutics and enhanced their efficacy while minimizing side effects. 

This Collection aims to showcase new research pushing the boundaries of drug delivery technology, paving the way for more effective and patient-centric therapeutic interventions. We invite contributions from across the field, including:

  • Nanoparticles for therapeutic delivery
  • Innovative liposomal approaches
  • Polymer micelles in drug transport
  • Advances in transdermal delivery
  • Precision targeting in drug delivery
  • Biodegradable polymers in drug carriers
  • Exploring nanomedicine applications
  • Emerging trends in oral drug delivery
  • Intravenous drug delivery innovations
  • Gene delivery vectors and beyond
  • Ocular and pulmonary drug delivery
  • Implantable and mucosal drug delivery

Image credit: catalin /

  1. Brucellosis poses a significant challenge in the medical field as a systemic infection with a propensity for relapse. This study presented a novel approach to brucellosis treatment, enhancing the efficacy of d...

    Authors: Saeideh Gohari, Seyed Mostafa Hosseini, Fatemeh Nouri, Rasoul Yousefimashouf, Mohammad Reza Arabestani and Mohammad Taheri
    Citation: BMC Chemistry 2024 18:100

Submission Guidelines

Back to top

This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Drug delivery systems" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.